2-210608346-G-T

Variant summary

Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_001875.5(CPS1):​c.2193-15G>T variant causes a splice polypyrimidine tract, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.123 in 1,608,256 control chromosomes in the GnomAD database, including 13,438 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.10 ( 999 hom., cov: 32)
Exomes 𝑓: 0.13 ( 12439 hom. )

Consequence

CPS1
NM_001875.5 splice_polypyrimidine_tract, intron

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:9

Conservation

PhyloP100: -0.141
Variant links:
Genes affected
CPS1 (HGNC:2323): (carbamoyl-phosphate synthase 1) The mitochondrial enzyme encoded by this gene catalyzes synthesis of carbamoyl phosphate from ammonia and bicarbonate. This reaction is the first committed step of the urea cycle, which is important in the removal of excess urea from cells. The encoded protein may also represent a core mitochondrial nucleoid protein. Three transcript variants encoding different isoforms have been found for this gene. The shortest isoform may not be localized to the mitochondrion. Mutations in this gene have been associated with carbamoyl phosphate synthetase deficiency, susceptibility to persistent pulmonary hypertension, and susceptibility to venoocclusive disease after bone marrow transplantation.[provided by RefSeq, May 2010]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.9).
BP6
Variant 2-210608346-G-T is Benign according to our data. Variant chr2-210608346-G-T is described in ClinVar as [Benign]. Clinvar id is 137023.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr2-210608346-G-T is described in Lovd as [Benign].
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.251 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
CPS1NM_001875.5 linkuse as main transcriptc.2193-15G>T splice_polypyrimidine_tract_variant, intron_variant ENST00000233072.10

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
CPS1ENST00000233072.10 linkuse as main transcriptc.2193-15G>T splice_polypyrimidine_tract_variant, intron_variant 1 NM_001875.5 P1P31327-1

Frequencies

GnomAD3 genomes
AF:
0.102
AC:
15515
AN:
151782
Hom.:
996
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0364
Gnomad AMI
AF:
0.0384
Gnomad AMR
AF:
0.133
Gnomad ASJ
AF:
0.138
Gnomad EAS
AF:
0.263
Gnomad SAS
AF:
0.145
Gnomad FIN
AF:
0.114
Gnomad MID
AF:
0.0823
Gnomad NFE
AF:
0.118
Gnomad OTH
AF:
0.102
GnomAD3 exomes
AF:
0.127
AC:
31517
AN:
249112
Hom.:
2250
AF XY:
0.127
AC XY:
17155
AN XY:
134794
show subpopulations
Gnomad AFR exome
AF:
0.0349
Gnomad AMR exome
AF:
0.133
Gnomad ASJ exome
AF:
0.138
Gnomad EAS exome
AF:
0.236
Gnomad SAS exome
AF:
0.132
Gnomad FIN exome
AF:
0.117
Gnomad NFE exome
AF:
0.120
Gnomad OTH exome
AF:
0.118
GnomAD4 exome
AF:
0.125
AC:
182204
AN:
1456356
Hom.:
12439
Cov.:
31
AF XY:
0.126
AC XY:
91408
AN XY:
724766
show subpopulations
Gnomad4 AFR exome
AF:
0.0328
Gnomad4 AMR exome
AF:
0.133
Gnomad4 ASJ exome
AF:
0.135
Gnomad4 EAS exome
AF:
0.291
Gnomad4 SAS exome
AF:
0.132
Gnomad4 FIN exome
AF:
0.113
Gnomad4 NFE exome
AF:
0.121
Gnomad4 OTH exome
AF:
0.130
GnomAD4 genome
AF:
0.102
AC:
15515
AN:
151900
Hom.:
999
Cov.:
32
AF XY:
0.104
AC XY:
7741
AN XY:
74220
show subpopulations
Gnomad4 AFR
AF:
0.0363
Gnomad4 AMR
AF:
0.133
Gnomad4 ASJ
AF:
0.138
Gnomad4 EAS
AF:
0.263
Gnomad4 SAS
AF:
0.144
Gnomad4 FIN
AF:
0.114
Gnomad4 NFE
AF:
0.118
Gnomad4 OTH
AF:
0.106
Alfa
AF:
0.0781
Hom.:
139
Bravo
AF:
0.0979
Asia WGS
AF:
0.237
AC:
822
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:9
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:4
Benign, criteria provided, single submitterclinical testingGeneDxJul 25, 2013This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -
Benign, no assertion criteria providedclinical testingClinical Genetics, Academic Medical Center-- -
Benign, no assertion criteria providedclinical testingJoint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+-- -
Benign, criteria provided, single submitterclinical testingPreventionGenetics, part of Exact Sciences-- -
Congenital hyperammonemia, type I Benign:4
Benign, criteria provided, single submitterclinical testingInvitaeFeb 01, 2024- -
Benign, criteria provided, single submitterclinical testingGenome-Nilou LabJul 10, 2021- -
Benign, criteria provided, single submitterclinical testingClinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical CenterMay 31, 2017- -
Benign, criteria provided, single submitterclinical testingIllumina Laboratory Services, IlluminaJan 12, 2018This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -
not provided Benign:1
Benign, criteria provided, single submitterclinical testingWomen's Health and Genetics/Laboratory Corporation of America, LabCorpMay 14, 2017Variant summary: c. c.2193-15G>T in CPS1 gene is an intronic change that involves a non-conserved nucleotide. 5/5 programs in Alamut predict that this do not affect a normal splicing, however no functional studies supporting this notion were published at the time of evaluation. The variant is present in the control population dataset of ExAC at frequency of 0.1255 (14937 / 119028 chrs tested), across multiple ethnicities, including numerous homozygous occurrences. The observed frequencies exceed the maximum expected allele frequency for a pathogenic variant of 0.0015%, suggesting that it is a benign polymorphism. The variant of interest has been reported as Benign by several reputable databases/clinical laboratory. Taking together, based on the prevalence of this variant in general population the variant was classified as Benign. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.90
CADD
Benign
0.23
DANN
Benign
0.39

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs2287600; hg19: chr2-211473070; COSMIC: COSV51812966; COSMIC: COSV51812966; API